£2.5M
The biotechnology funding pairs strategic capital with a collaborative agreement to explore oncology opportunities.
AD
AMPLY Discovery
AMPLY Discovery develops therapeutic programmes using artificial intelligence and experimental testing.
£4.7MTotal raised
AMPLY Discovery is an artificial intelligence driven drug discovery company based in the United Kingdom. The firm leverages multi-omic datasets and laboratory testing to generate therapeutic programmes for partnering.
Categories
Founders
DT
Dermot Tierney
Co-Founder and Chief Operating Officer
Investors
- £2.5M
- £1.3M
- £900K
Funding history
£1.3M
Twin Path Ventures led the seed financing for the Belfast biotechnology firm to accelerate its preclinical discovery programmes.
£900K
The Belfast biotechnology company raised the capital from investors including Co-fund NI, QUBIS, and the Halo Business Angel Network.